Antimicrobial resistance (AMR) is a pressing global health threat, posing challenges to the effective treatment of infectious diseases and undermining decades of medical progress. In the face of rising resistance rates, the development of new antimicrobial agents, antibiotics, and antibacterial therapies is paramount to combatting drug-resistant pathogens and safeguarding public health. This session delves into the latest research, innovations, and strategies surrounding antimicrobials, antibiotics, and antibacterial agents, aiming to address the evolving landscape of antimicrobial stewardship, resistance mechanisms, and therapeutic interventions.